Evaluation of storage and evaporation in the removal efficiency of D-norgestrel and progesterone in human urine

Environ Monit Assess. 2015 Oct;187(10):619. doi: 10.1007/s10661-015-4838-2. Epub 2015 Sep 10.

Abstract

Pharmaceuticals are emerging contaminants and it must be noted that approximately 70 % of them are excreted via urine. Therefore, urine usage implies the risk of transfer of pharmaceutical residues to agricultural fields and environment contamination. Thus, this study aimed on the development and validation of a LC-MS/MS method for D-norgestrel (D-NOR) and progesterone (PRO) determination in human urine, as well as the evaluation of the removal efficiency of two methods (storage and evaporation), and the effects of acidification with sulfuric acid. The storage process was evaluated for 6 weeks, while the evaporation was assessed at three different temperatures (50, 75, and 100 °C). All experiments were done with normal urine (pH = 6.0) and acidified urine (pH = 2.0, with sulfuric acid). The results of validation showed good method efficiency. In the second week of storage, higher hormone degradation was observed. In the evaporation method, both D-NOR and PRO were almost completely degraded when the volume was reduced to the lowermost level. Results also indicate that acidification did not affect degradation. Overall, the results showed that combination of two methods can be employed for more efficient hormone removal in urine.

Keywords: Evaporation; Hormones; Human urine; LC-MS/MS; Storage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Chromatography, Liquid
  • Environmental Monitoring / methods*
  • Healthy Volunteers
  • Humans
  • Levonorgestrel / isolation & purification*
  • Levonorgestrel / urine
  • Limit of Detection
  • Male
  • Progesterone / isolation & purification*
  • Progesterone / urine
  • Reproducibility of Results
  • Specimen Handling
  • Tandem Mass Spectrometry / methods
  • Temperature
  • Urine / chemistry*
  • Volatilization
  • Young Adult

Substances

  • Progesterone
  • Levonorgestrel